Skip to content

Bioteekki Kurkkutabletti

by Dr. Müller Pharma s.r.o. Czech Republic EUDAMED

Ref PC8913_007

EMDN V9017

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number2023-MDR/QS-034/D Date12 Oct 2026IssuedStatusActive expires 20 Oct 2028

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • 2023-MDR/QS-034/D Supplemented

    Quality management system EU MDR

    Notified body
    3EC International a.s. 2265
    Issued
    12 Oct 2026
    Expires
    20 Oct 2028
    Reason
    Change approved

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Pastilles
Model / Reference
PC8913_007
Primary DI / UDI-DI
08595610408220
Basic UDI-DI
85956104SLHR
EMDN Code
V9017 Oral administration preparations not included in other classes
Device Class
Class IIa
Market of Registration
Finland

Manufacturer details

EUDAMED SRN
CZ-MF-000000005

Properties & raw data

Show properties, registry sources and raw records
Other properties (13)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED b975aadf-4507-447a-b11c-995c6d7bc21e 61 fields · synced 22 Oct 2026